Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands
For a variety of cancer types, platinum compounds are still among the best treatment options. However, their application is limited by side effects and drug resistance. Consequently, multi-targeted platinum(IV) prodrugs that target specific traits of the malignant tissue are interesting new candidat...
Saved in:
Main Authors: | Theresa Mendrina (Author), Isabella Poetsch (Author), Hemma Schueffl (Author), Dina Baier (Author), Christine Pirker (Author), Alexander Ries (Author), Bernhard K. Keppler (Author), Christian R. Kowol (Author), Dan Gibson (Author), Michael Grusch (Author), Walter Berger (Author), Petra Heffeter (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells
by: Al-Keilani MS, et al.
Published: (2018) -
The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation
by: Dina Baier, et al.
Published: (2022) -
Development of α-Cyclodextrin-Based Orally Disintegrating Tablets for 4-Phenylbutyrate
by: Kindness L. Commey, et al.
Published: (2024) -
Neuroprotective Effect of 4-Phenylbutyric Acid against Photo-Stress in the Retina
by: Naymel Alejandra Guzmán Mendoza, et al.
Published: (2021) -
Analysis of the axial stability for an assembly of optical modes with stochastic fluctuations type Markov chain
by: Martinez Vara P, et al.
Published: (2020)